Skip to main content
Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.4445
-0.0011 (-0.25%)
At close: Nov 11, 2026, 4:00 PM EST
0.4599
+0.0154 (3.46%)
Pre-market: Nov 12, 2026, 8:14 AM EST

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Biotechnology (Startups)
285.76K1.50M583.23K--
Total
285.76K1.50M583.23K--

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
United States
285.76K1.50M583.23K--
Total
285.76K1.50M583.23K--